NOX1 and chronic obstructive pulmonary disease: Examples are: apocynin, which by nebulization reduces H2O2 and the reduction of nitrites in the exhaled breath condensate of COPD patients [222,223]; setanaxib, which is an NOX1/4 inhibitor currently under development that has demonstrated excellent tolerability and reduction of various markers of chronic inflammation [224].